GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
J2357
Injection, omalizumab, 5 mg
HCPCS code
Medical Policies and Guidelines for Injection, omalizumab, 5 mg
Related policies from health plans
ANTHEM-BLUECROSS-CA
Xolair (omalizumab)
SUNFLOWER
XOLAIR, Omalizumab
Similar Codes
ICD10CM codes
Z29.1
- Encounter for prophylactic immunotherapy
Z29.13
- Encounter for prophylactic Rho(D) immune globulin
T50.Z16
- Underdosing of immunoglobulin
Z30.013
- Encounter for initial prescription of injectable contraceptive
T50.Z16A
- Underdosing of immunoglobulin, initial encounter
Z51.12
- Encounter for antineoplastic immunotherapy
Z30.42
- Encounter for surveillance of injectable contraceptive
T50.Z15A
- Adverse effect of immunoglobulin, initial encounter
T50.Z14
- Poisoning by immunoglobulin, undetermined
T50.Z15D
- Adverse effect of immunoglobulin, subsequent encounter
HCPCS codes
J2357
- Injection, omalizumab, 5 mg
J2350
- Injection, ocrelizumab, 1 mg
J0791
- Injection, crizanlizumab-tmca, 5 mg
J7170
- Injection, emicizumab-kxwh, 0.5 mg
J9353
- Injection, margetuximab-cmkb, 5 mg
J3262
- Injection, tocilizumab, 1 mg
C9473
- Injection, mepolizumab, 1 mg
J0517
- Injection, benralizumab, 1 mg
J0875
- Injection, dalbavancin, 5 mg
J9308
- Injection, ramucirumab, 5 mg
CPT4 codes
90284
- Immune globulin (SCIg), human, for use in subcutaneous infusions, 100 mg, each
90281
- Immune globulin (Ig), human, for intramuscular use
80280
- Vedolizumab
80230
- Infliximab
90396
- Varicella-zoster immune globulin, human, for intramuscular use
82785
- Gammaglobulin (immunoglobulin); IgE
90399
- Unlisted immune globulin
80145
- Adalimumab
11952
- Subcutaneous injection of filling material (eg, collagen); 5.1 to 10.0 cc
90375
- Rabies immune globulin (RIg), human, for intramuscular and/or subcutaneous use